Impact of 2012 USPSTF guideline against PSA screening explored

Impact of 2012 USPSTF guideline against PSA screening explored

(HealthDay)—Patients undergoing prostate needle biopsies after the 2012 U.S. Preventive Services Task Force (USPSTF) recommendation against prostate-specific antigen-based screening for prostate cancer for men of any age are more likely to be diagnosed with high-risk disease, according to research published in the January issue of The Journal of Urology.

John S. Banerji, M.D., from the Virginia Mason Medical Center in Seattle, and colleagues reviewed data from a prospective database of patients undergoing prostate needle biopsies from 2004 to 2014. The authors compared patients seen before and after the USPSTF recommendations.

The researchers found that, compared with the 1,416 patients in the pre-USPSTF group, the 310 patients in the post-USPSTF group had a higher prostate-specific antigen (P < 0.001); they were also more likely to be diagnosed with higher clinical stage (2b, P = 0.003; 2c-3a, P = 0.027) and D'Amico high-risk prostate cancer (P = 0.036), with an adjusted relative risk of 1.25 for high-risk prostate cancer. Similar results were seen when the pre-USPSTF group was limited to 448 seen in the 30 months before the draft guidelines. There was a 31 percent decrease in the absolute number of biopsies performed, with most of the decrease occurring in the detection of intermediate-risk tumors.

"Future focus on informed application of screening techniques may prevent the reversal of decades of improvement in the mortality rate," the authors write.


Explore further

Studies find decline in rates of PSA screening, early-stage prostate cancer

More information: Abstract
Full Text
Journal information: Journal of Urology

Copyright © 2015 HealthDay. All rights reserved.

Citation: Impact of 2012 USPSTF guideline against PSA screening explored (2015, December 29) retrieved 23 October 2019 from https://medicalxpress.com/news/2015-12-impact-uspstf-guideline-psa-screening.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments

Dec 29, 2015
"There was a 31 percent decrease in the absolute number of biopsies performed, with most of the decrease occurring in the detection of intermediate-risk tumors." These presumably are the patients that could be cured -- but will now die because of the new guidelines.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more